Portuguese English Spanish
Interface
Adjust the interface to make it easier to use for different conditions.
This renders the document in high contrast mode.
This renders the document as white on black
This can help those with trouble processing rapid screen movements.
This loads a font easier to read for people with dyslexia.
Busca Avançada
Você está aqui: Notícias » Pesquisadores do IOC participam de Conferência Internacional de Aids

Pesquisadores do IOC participam de Conferência Internacional de Aids

Evento realizado no México entre 3 e 8 de agosto reuniu cerca de 22 mil participantes de todo o mundo
Por Jornalismo IOC05/08/2008 - Atualizado em 10/12/2019

Promovida bienalmente pela Sociedade Internacional de Aids (IAS, nas sigla em inglês), a Conferência Mundial de Aids 2008 reuniu especialistas de todo o mundo na Cidade do México, de 3 a 8 de agosto, para discutir os principais avanços e desafios no enfrentamento da epidemia. Pesquisadores do Instituto Oswaldo Cruz (IOC/Fiocruz) integraram o evento em mesas-redondas e apresentações orais. Confira a cobertura completa no site do evento.

Os pesquisadores do IOC participaram com as seguintes atividades:

Segunda-feira (dia 04)
The Toll-like receptor 2 ligand Zymosan inhibits HIV-1 replication in human primary cells
H.K. Pimenta-Inada, L.G. Jucá, C.C. Cirne-Santos, D.C. Bou-Habib

Trypanosomatid replication in HIVinfected macrophages
D. Chequer Bou-Habib

Interleukin 27 (IL-27) inhibits HIV-1 replication in primary human cells independently of beta-chemokine production
L. Gobbo Jucá, H. Kimie Pimenta-Inada, C.Cesar Cirne-Santos, D. Chequer Bou-Habib

Trends of integrase inhibitors drug resistance in treatment-naive patients with HIV-1 subtype C infection in Brazil
C. Passaes, M. Guimarães, S. Almeida, M.Morgado

Temporal trends and evolutionary history of HIV-1 CRF31_BC in Porto Alegre, Brazil from 1998 to 2006
M. Guimarães, C. Passaes, G. Bello, R.Lorete, S. Almeida, R. Medeiros, P.R.Alencastro, M. Morgado

Evaluation of the impact of HIV-1 genetic diversity subtypes in the antiretroviral therapy efficacy in infected patients in Rio de Janeiro, Brazil: a follow up study
S. Chequer Fernandez, C. Santos Rodrigues, D. Rufino dos Santos, J.H. Pilotto, M. Morgado

Terça-feira (dia 05)
Low emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant Women in Rio de Janeiro, Brazil
J.H. Pilotto, B. Grinsztejn, V.G. Veloso,J.-C. Couto-Fernandez, A. Rodrigues-Pedro, J.E. Ribeiro, E. Lima, R. Khalili, S. Muri, R.Ismerio, J. Currier, M.G. Morgado

The compound 6-chloro-1,4-dihydro-4-oxo-1-(&946;-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase
D. Rodrigues, T. Souza, C. Cirne-Santos,C.F. Fontes, V. Ferreira, I. Marquez, M.C. DeSouza, D. Bou-Habib

Quarta-feira (dia 06)
Preclinical development / Preclinical Development and Animal Models for HIV Vaccines
M. Morgado

Evaluation of the ViroSeq HIV-1 genotyping system performance in prevalent non-B and recombinant HIV-1 samples from patients failing antiretroviral therapy in Rio de Janeiro
J.C. Couto-Fernandez, C. Silva de Jesus, M.Morgado

Quinta-feira (dia 07)
Evidence of multiple HIV-1 subtype C introductions in Southeast Brazilian region
G. Bello, M. Guimarães, J.C. Couto-Fernandez, C. Passaes, J. Casseb, S.Almeida, R. Alcade, M. Morgado

HIV-1 replication is enhancend by the macrophage migration inhibitory factor
E. Regis, V. Barreto-de-Souza Brasil Silva,L. Leng, R. Bucala, M. Bozza, D.C. Bou-Habib

The neurotrophins NGF, BDNF and proNGF induce enhancement of HIV-1 replication in primary human macrophages
T. Souza, D. Rodrigues, E. Araujo, C. Fontes,D. Bou-Habib

09/08/08

.

Evento realizado no México entre 3 e 8 de agosto reuniu cerca de 22 mil participantes de todo o mundo
Por: 
jornalismo

Promovida bienalmente pela Sociedade Internacional de Aids (IAS, nas sigla em inglês), a Conferência Mundial de Aids 2008 reuniu especialistas de todo o mundo na Cidade do México, de 3 a 8 de agosto, para discutir os principais avanços e desafios no enfrentamento da epidemia. Pesquisadores do Instituto Oswaldo Cruz (IOC/Fiocruz) integraram o evento em mesas-redondas e apresentações orais. Confira a cobertura completa no site do evento.

Os pesquisadores do IOC participaram com as seguintes atividades:

Segunda-feira (dia 04)

The Toll-like receptor 2 ligand Zymosan inhibits HIV-1 replication in human primary cells

H.K. Pimenta-Inada, L.G. Jucá, C.C. Cirne-Santos, D.C. Bou-Habib

Trypanosomatid replication in HIVinfected macrophages

D. Chequer Bou-Habib

Interleukin 27 (IL-27) inhibits HIV-1 replication in primary human cells independently of beta-chemokine production

L. Gobbo Jucá, H. Kimie Pimenta-Inada, C.Cesar Cirne-Santos, D. Chequer Bou-Habib

Trends of integrase inhibitors drug resistance in treatment-naive patients with HIV-1 subtype C infection in Brazil

C. Passaes, M. Guimarães, S. Almeida, M.Morgado

Temporal trends and evolutionary history of HIV-1 CRF31_BC in Porto Alegre, Brazil from 1998 to 2006

M. Guimarães, C. Passaes, G. Bello, R.Lorete, S. Almeida, R. Medeiros, P.R.Alencastro, M. Morgado

Evaluation of the impact of HIV-1 genetic diversity subtypes in the antiretroviral therapy efficacy in infected patients in Rio de Janeiro, Brazil: a follow up study

S. Chequer Fernandez, C. Santos Rodrigues, D. Rufino dos Santos, J.H. Pilotto, M. Morgado

Terça-feira (dia 05)

Low emergence of drug resistance after HAART interruption at delivery in a cohort of HIV+ pregnant Women in Rio de Janeiro, Brazil

J.H. Pilotto, B. Grinsztejn, V.G. Veloso,J.-C. Couto-Fernandez, A. Rodrigues-Pedro, J.E. Ribeiro, E. Lima, R. Khalili, S. Muri, R.Ismerio, J. Currier, M.G. Morgado

The compound 6-chloro-1,4-dihydro-4-oxo-1-(&946;-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase

D. Rodrigues, T. Souza, C. Cirne-Santos,C.F. Fontes, V. Ferreira, I. Marquez, M.C. DeSouza, D. Bou-Habib

Quarta-feira (dia 06)

Preclinical development / Preclinical Development and Animal Models for HIV Vaccines

M. Morgado

Evaluation of the ViroSeq HIV-1 genotyping system performance in prevalent non-B and recombinant HIV-1 samples from patients failing antiretroviral therapy in Rio de Janeiro

J.C. Couto-Fernandez, C. Silva de Jesus, M.Morgado

Quinta-feira (dia 07)

Evidence of multiple HIV-1 subtype C introductions in Southeast Brazilian region

G. Bello, M. Guimarães, J.C. Couto-Fernandez, C. Passaes, J. Casseb, S.Almeida, R. Alcade, M. Morgado

HIV-1 replication is enhancend by the macrophage migration inhibitory factor

E. Regis, V. Barreto-de-Souza Brasil Silva,L. Leng, R. Bucala, M. Bozza, D.C. Bou-Habib

The neurotrophins NGF, BDNF and proNGF induce enhancement of HIV-1 replication in primary human macrophages

T. Souza, D. Rodrigues, E. Araujo, C. Fontes,D. Bou-Habib

09/08/08

.

Permitida a reprodução sem fins lucrativos do texto desde que citada a fonte (Comunicação / Instituto Oswaldo Cruz)